OXCIA Trademark

Trademark Overview

On Wednesday, February 23, 2022, a trademark application was filed for OXCIA with the United States Patent and Trademark Office. The USPTO has given the OXCIA trademark a serial number of 79336842. The federal status of this trademark filing is EX PARTE APPEAL PENDING as of Wednesday, August 28, 2024. This trademark is owned by Oxcia AB. The OXCIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, inflammation, pulmonary fibrosis, sepsis, respiratory diseases, psoriasis and Crohn's disease
oxcia

General Information

Serial Number79336842
Word MarkOXCIA
Filing DateWednesday, February 23, 2022
Status760 - EX PARTE APPEAL PENDING
Status DateWednesday, August 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer, inflammation, pulmonary fibrosis, sepsis, respiratory diseases, psoriasis and Crohn's disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOxcia AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events

Event DateEvent Description
Thursday, March 31, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 4, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, April 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 9, 2022APPLICATION FILING RECEIPT MAILED
Friday, October 28, 2022NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, December 7, 2022ASSIGNED TO EXAMINER
Thursday, December 8, 2022NON-FINAL ACTION WRITTEN
Friday, December 9, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 3, 2023REFUSAL PROCESSED BY MPU
Friday, February 3, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, February 27, 2023REFUSAL PROCESSED BY IB
Thursday, August 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 30, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Saturday, September 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, February 6, 2024FINAL REFUSAL WRITTEN
Tuesday, February 6, 2024FINAL REFUSAL E-MAILED
Tuesday, February 6, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, August 6, 2024EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, August 6, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, August 6, 2024EX PARTE APPEAL-INSTITUTED
Tuesday, August 6, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, August 27, 2024NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Tuesday, August 27, 2024ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Friday, November 8, 2024EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Tuesday, August 27, 2024ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED

Related Keywords

oxcia diseases respiratory psoriasis crohn disease sepsis fibrosis treatment preparations cancer